By Ben Hirschler LONDON (Reuters) - Bristol-Myers Squibb, Sanofi and Novartis have the three top new drugs set to reach the market in 2015, among 11 products each with $1 billion-plus sales potential, according to a Thomson Reuters analysis. More potential blockbusters are expected to be launched this year than last, in an encouraging sign for the pharmaceutical industry, which relies on new products to replenish sales as older medicines go off patent. Regulators have been approving more new drugs in recent years but there remains a debate as to how far this will translate into bigger overall sales and profits, since many modern medicines are for rare diseases.
March 23, 2015 at 09:50AM
via Lazahealth.org
No comments:
Post a Comment